117 related articles for article (PubMed ID: 38758843)
21. Patterns of care for patients with primary differentiated carcinoma of the thyroid gland treated in Germany during 1996. U.S. and German Thyroid Cancer Group.
Hölzer S; Reiners C; Mann K; Bamberg M; Rothmund M; Dudeck J; Stewart AK; Hundahl SA
Cancer; 2000 Jul; 89(1):192-201. PubMed ID: 10897018
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis, treatment, and outcome of follicular thyroid carcinoma.
Emerick GT; Duh QY; Siperstein AE; Burrow GN; Clark OH
Cancer; 1993 Dec; 72(11):3287-95. PubMed ID: 8080485
[TBL] [Abstract][Full Text] [Related]
23. Lenvatinib: Role in thyroid cancer and other solid tumors.
Cabanillas ME; Habra MA
Cancer Treat Rev; 2016 Jan; 42():47-55. PubMed ID: 26678514
[TBL] [Abstract][Full Text] [Related]
24. Control of Lung Metastases and Colon Polyposis with Lenvatinib Therapy in a Patient with Cribriform-Morular Variant of Papillary Thyroid Carcinoma and an
Ito Y; Ishikawa H; Kihara M; Hirokawa M; Kiyota N; Kasahara T; Miyauchi A
Thyroid; 2019 Oct; 29(10):1511-1517. PubMed ID: 31317827
[No Abstract] [Full Text] [Related]
25. [Lenvatinib in radioiodine refractory thyroid carcinomas].
de la Fouchardiere C
Bull Cancer; 2016 Nov; 103(11):905-910. PubMed ID: 27817859
[TBL] [Abstract][Full Text] [Related]
26. Skull metastasis from follicular thyroid carcinoma: report of three cases and review of literature.
Shen J; Wang S; Zhao X; Shao X; Jiang X; Dai Y; Xu S; Pan X
Int J Clin Exp Pathol; 2015; 8(11):15285-93. PubMed ID: 26823882
[TBL] [Abstract][Full Text] [Related]
27. Improved Survival After Multimodal Approach with
Wu D; Gomes Lima CJ; Moreau SL; Kulkarni K; Zeymo A; Burman KD; Wartofsky L; Van Nostrand D
Thyroid; 2019 Jul; 29(7):971-978. PubMed ID: 31017051
[No Abstract] [Full Text] [Related]
28. [Effectiveness of Lenvatinib for Thyroid Cancer with Lung Metastases - Report of a Case].
Nagashima S; Matsuo S; Takahashi M; Umemoto Y; Hirano T; Enomoto K; Sakurai K; Amano S
Gan To Kagaku Ryoho; 2016 Nov; 43(12):2121-2123. PubMed ID: 28133242
[TBL] [Abstract][Full Text] [Related]
29. [Multi-modality therapy concept in metastatic follicular thyroid carcinoma with hyperthyroidism].
Brauckhoff M; Dorsch K; Hädecke J; Kujat C; Straube F; Krause U; Dralle H
Chirurg; 2001 Jan; 72(1):37-42. PubMed ID: 11225454
[TBL] [Abstract][Full Text] [Related]
30. Thyroglobulin fluctuations in patients with iodine-refractory differentiated thyroid carcinoma on lenvatinib treatment - initial experience.
Werner RA; Lückerath K; Schmid JS; Higuchi T; Kreissl MC; Grelle I; Reiners C; Buck AK; Lapa C
Sci Rep; 2016 Jun; 6():28081. PubMed ID: 27306607
[TBL] [Abstract][Full Text] [Related]
31. Extended Real-World Observation of Patients Treated with Sorafenib for Radioactive Iodine-Refractory Differentiated Thyroid Carcinoma and Impact of Lenvatinib Salvage Treatment: A Korean Multicenter Study.
Oh HS; Shin DY; Kim M; Park SY; Kim TH; Kim BH; Kim EY; Kim WB; Chung JH; Shong YK; Lim DJ; Kim WG
Thyroid; 2019 Dec; 29(12):1804-1810. PubMed ID: 31592739
[No Abstract] [Full Text] [Related]
32. Treatment of refractory thyroid cancer.
Berdelou A; Lamartina L; Klain M; Leboulleux S; Schlumberger M
Endocr Relat Cancer; 2018 Apr; 25(4):R209-R223. PubMed ID: 29371330
[TBL] [Abstract][Full Text] [Related]
33. Notable decrease of malignant pleural effusion after treatment with sorafenib in radioiodine-refractory follicular thyroid carcinoma.
Liu M; Shen Y; Ruan M; Li M; Chen L
Thyroid; 2014 Jul; 24(7):1179-83. PubMed ID: 24684401
[TBL] [Abstract][Full Text] [Related]
34. Lesion-Based Evaluation Predicts Treatment Response to Lenvatinib for Radioactive Iodine-Refractory Differentiated Thyroid Cancer: A Korean Multicenter Retrospective Study.
Lee EK; Kim SM; Kim BH; Kim MJ; Lim DJ; Kim MH; Shin DY; Kang HC; Ahn BC; Kim SW; Ahn HY; Park YJ
Thyroid; 2019 Dec; 29(12):1811-1819. PubMed ID: 31482759
[No Abstract] [Full Text] [Related]
35. Brain metastasis from follicular thyroid carcinoma: treatment with sorafenib.
Shen Y; Ruan M; Luo Q; Yu Y; Lu H; Zhu R; Chen L
Thyroid; 2012 Aug; 22(8):856-60. PubMed ID: 22793259
[TBL] [Abstract][Full Text] [Related]
36. Molecular targets of tyrosine kinase inhibitors in thyroid cancer.
Fallahi P; Ferrari SM; Galdiero MR; Varricchi G; Elia G; Ragusa F; Paparo SR; Benvenga S; Antonelli A
Semin Cancer Biol; 2022 Feb; 79():180-196. PubMed ID: 33249201
[TBL] [Abstract][Full Text] [Related]
37. Salvage Lenvatinib Therapy in Metastatic Anaplastic Thyroid Cancer.
Iñiguez-Ariza NM; Ryder MM; Hilger CR; Bible KC
Thyroid; 2017 Jul; 27(7):923-927. PubMed ID: 28471306
[TBL] [Abstract][Full Text] [Related]
38. Follicular thyroid carcinoma: metastasis to the sternum, 13 years after total thyroidectomy.
Eroglu A; Karaoglanoglu N; Bilen H; Gursan N
Int J Clin Pract; 2006 Nov; 60(11):1506-8. PubMed ID: 17073845
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary approach to follicular thyroid carcinoma with giant mandibular and multiple sites metastases Case report.
De Pasquale L; Rabbiosi D; Bardazzi A; Autelitano L; Moro GP; Ghilardi G
Ann Ital Chir; 2014; 85(6):601-5. PubMed ID: 25712423
[TBL] [Abstract][Full Text] [Related]
40. Lenvatinib induces early tumor shrinkage in patients with advanced thyroid carcinoma.
Masaki C; Sugino K; Saito N; Saito Y; Tanaka T; Ogimi Y; Maeda T; Osaku T; Akaishi J; Hames KY; Tomoda C; Suzuki A; Matsuzu K; Uruno T; Ohkuwa K; Kitagawa W; Nagahama M; Takami H; Ito K
Endocr J; 2017 Aug; 64(8):819-826. PubMed ID: 28659544
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
